Loading...
Recent translational research: antiangiogenic therapy for breast cancer – where do we stand?
The central importance of angiogenesis and our understanding of how new blood vessels are formed have led to the development of novel antiangiogenic therapies. Although the number of agents in development has grown exponentially, only one phase III trial in breast cancer has been completed. In that...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2004
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC400679/ https://ncbi.nlm.nih.gov/pubmed/15084233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr782 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|